Anti-GRIA1/ GLUH1/ GLUR1 monoclonal antibody

Anti-GRIA1/ GLUH1/ GLUR1 antibody for FACS & in-vivo assay

Target products collectionGo to GRIA1/GRIA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T33584-Ab-1/ GM-Tg-hg-T33584-Ab-2Anti-Human GRIA1 monoclonal antibodyHuman
GM-Tg-rg-T33584-Ab-1/ GM-Tg-rg-T33584-Ab-2Anti-Rat GRIA1 monoclonal antibodyRat
GM-Tg-mg-T33584-Ab-1/ GM-Tg-mg-T33584-Ab-2Anti-Mouse GRIA1 monoclonal antibodyMouse
GM-Tg-cynog-T33584-Ab-1/ GM-Tg-cynog-T33584-Ab-2Anti-Cynomolgus/ Rhesus macaque GRIA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T33584-Ab-1/ GM-Tg-felg-T33584-Ab-2Anti-Feline GRIA1 monoclonal antibodyFeline
GM-Tg-cang-T33584-Ab-1/ GM-Tg-cang-T33584-Ab-2Anti-Canine GRIA1 monoclonal antibodyCanine
GM-Tg-bovg-T33584-Ab-1/ GM-Tg-bovg-T33584-Ab-2Anti-Bovine GRIA1 monoclonal antibodyBovine
GM-Tg-equg-T33584-Ab-1/ GM-Tg-equg-T33584-Ab-2Anti-Equine GRIA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T33584-Ab-1/ GM-Tg-hg-T33584-Ab-2; GM-Tg-rg-T33584-Ab-1/ GM-Tg-rg-T33584-Ab-2;
GM-Tg-mg-T33584-Ab-1/ GM-Tg-mg-T33584-Ab-2; GM-Tg-cynog-T33584-Ab-1/ GM-Tg-cynog-T33584-Ab-2;
GM-Tg-felg-T33584-Ab-1/ GM-Tg-felg-T33584-Ab-2; GM-Tg-cang-T33584-Ab-1/ GM-Tg-cang-T33584-Ab-2;
GM-Tg-bovg-T33584-Ab-1/ GM-Tg-bovg-T33584-Ab-2; GM-Tg-equg-T33584-Ab-1/ GM-Tg-equg-T33584-Ab-2
Products NameAnti-GRIA1 monoclonal antibody
Formatmab
Target NameGRIA1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GRIA1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GRIA1/ GLUH1/ GLUR1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004794mouse Gria1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004794mouse Gria1 Lentivirus particle


    Target information

    Target IDGM-T33584
    Target NameGRIA1
    Gene ID2890,14799,50592,714117,489168,101097621,529618,100060020
    Gene Symbol and Synonyms2900051M01Rik,Glr-1,Glr1,GluA1,GLUH1,Glur-1,GluR-A,gluR-K1,GLUR1,GLURA,GRIA1,HBGR1,HIPA1,MRD67,MRT76
    Uniprot AccessionP42261,P19490
    Uniprot Entry NameGRIA1_HUMAN,GRIA1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000155511
    Target ClassificationN/A

    The target: GRIA1, gene name: GRIA1, also named as GLUH1, GLUR1, GLURA, GluA1, HBGR1. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes with multiple subunits, each possessing transmembrane regions, and all arranged to form a ligand-gated ion channel. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. This gene belongs to a family of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.